(Q44410737)

English

Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils

scientific article published on April 25, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils (English)

1 reference

Europe PubMed Central

2 December 2017

cerebral infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kiyotaka Katsuta

1

1 reference

Europe PubMed Central

2 December 2017

Kazuo Umemura

2

1 reference

Europe PubMed Central

2 December 2017

Noriko Ueyama

3

1 reference

Europe PubMed Central

2 December 2017

Nobuya Matsuoka

4

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

2 December 2017

25 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706462

26 December 2023

full work available at URL

https://hama-med.repo.nii.ac.jp/?action=repository_action_common_download&item_id=289&item_no=1&attribute_id=31&file_no=1

Portable Document Format

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706462

26 December 2023

https://api.elsevier.com/content/article/PII:S0014299903015735?httpAccept=text/xml

1 reference

10.1016/S0014-2999(03)01573-5

https://api.crossref.org/works/10.1016/S0014-2999(03)01573-5

26 December 2023

https://api.elsevier.com/content/article/PII:S0014299903015735?httpAccept=text/plain

1 reference

10.1016/S0014-2999(03)01573-5

https://api.crossref.org/works/10.1016/S0014-2999(03)01573-5

26 December 2023

European Journal of Pharmacology

1 reference

Europe PubMed Central

2 December 2017

467

1 reference

Europe PubMed Central

2 December 2017

1-3

1 reference

Europe PubMed Central

2 December 2017

103-109

1 reference

Europe PubMed Central

2 December 2017

Locomotor activity in the ischemic gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Impaired acquisition of the Morris water maze following global ischemic damage in the gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Cerebral ischemia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Delayed neuronal death in the gerbil hippocampus following ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Selective vulnerability in the gerbil hippocampus following transient ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Nizofenone, a neuroprotective drug, suppresses glutamate release and lactate accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Effect of cyclooxygenase and lipoxygenase inhibitors on delayed neuronal death in the gerbil hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Protective effect of FR115427 against ischemic hippocampal damage in gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Cerebral ischemia, locomotor activity and spatial mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

Motor activity changes following cerebral ischemia in gerbils are correlated with the degree of neuronal degeneration in hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901573-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(03)01573-5

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44410737&oldid=2037163364"